These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
241 related items for PubMed ID: 10391155
1. Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer. Prospective randomised trial with standard operative and histopathological techniques. Dutch ColoRectal Cancer Group. Kapiteijn E, Kranenbarg EK, Steup WH, Taat CW, Rutten HJ, Wiggers T, van Krieken JH, Hermans J, Leer JW, van de Velde CJ. Eur J Surg; 1999 May; 165(5):410-20. PubMed ID: 10391155 [Abstract] [Full Text] [Related]
3. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy]. Thomschke D, Kyau-Ummen B, Halbfass HJ. Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499 [Abstract] [Full Text] [Related]
4. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands. Kapiteijn E, Putter H, van de Velde CJ, Cooperative investigators of the Dutch ColoRectal Cancer Group. Br J Surg; 2002 Sep; 89(9):1142-9. PubMed ID: 12190680 [Abstract] [Full Text] [Related]
6. Cost-utility analysis of preoperative radiotherapy in patients with rectal cancer undergoing total mesorectal excision: a study of the Dutch Colorectal Cancer Group. Van Den Brink M, Van Den Hout WB, Stiggelbout AM, Klein Kranenbarg E, Marijnen CA, Van De Velde CJ, Kievit J, Dutch Colorectal Cancer Group. J Clin Oncol; 2004 Jan 15; 22(2):244-53. PubMed ID: 14665610 [Abstract] [Full Text] [Related]
7. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients--a Dutch colorectal cancer group study. Peeters KC, van de Velde CJ, Leer JW, Martijn H, Junggeburt JM, Kranenbarg EK, Steup WH, Wiggers T, Rutten HJ, Marijnen CA. J Clin Oncol; 2005 Sep 01; 23(25):6199-206. PubMed ID: 16135487 [Abstract] [Full Text] [Related]
9. Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial. Kusters M, Marijnen CA, van de Velde CJ, Rutten HJ, Lahaye MJ, Kim JH, Beets-Tan RG, Beets GL. Eur J Surg Oncol; 2010 May 01; 36(5):470-6. PubMed ID: 20096534 [Abstract] [Full Text] [Related]
10. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM). Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1129-39. PubMed ID: 16414206 [Abstract] [Full Text] [Related]
11. Quality assurance in rectal cancer treatment. van de Velde CJ, van den Broek CB. Dig Dis; 2012 Mar 15; 30 Suppl 2():126-31. PubMed ID: 23207944 [Abstract] [Full Text] [Related]
12. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients. Bonnen M, Crane C, Vauthey JN, Skibber J, Delclos ME, Rodriguez-Bigas M, Hoff PM, Lin E, Eng C, Wong A, Janjan NA, Feig BW. Int J Radiat Oncol Biol Phys; 2004 Nov 15; 60(4):1098-105. PubMed ID: 15519780 [Abstract] [Full Text] [Related]
13. Local recurrence rate in a randomised multicentre trial of preoperative radiotherapy compared with operation alone in resectable rectal carcinoma. Swedish Rectal Cancer Trial. Eur J Surg; 1996 May 15; 162(5):397-402. PubMed ID: 8781922 [Abstract] [Full Text] [Related]
14. Introduction of preoperative radiotherapy in the treatment of operable rectal cancer in the Southwest region of the Netherlands. Vermaas M, Gosselink MP, Ferenschild FT, van den Aardweg E, Lont HE, Kemperman HW, van der Harst E, Tetteroo GW, Oostenbroek RJ, Dijkhuis CM, Eggermont AM, de Wilt JH. Eur J Surg Oncol; 2007 Sep 15; 33(7):862-7. PubMed ID: 17257804 [Abstract] [Full Text] [Related]
15. Surgical outcomes after total mesorectal excision for rectal cancer. Chiappa A, Biffi R, Bertani E, Zbar AP, Pace U, Crotti C, Biella F, Viale G, Orecchia R, Pruneri G, Poldi D, Andreoni B. J Surg Oncol; 2006 Sep 01; 94(3):182-93; discussion 181. PubMed ID: 16900534 [Abstract] [Full Text] [Related]
16. [Effect of total mesorectal excision and preoperative chemoradiotherapy on local recurrence in rectal cancer]. Wu AW, Gu J, Wang J. Zhonghua Wei Chang Wai Ke Za Zhi; 2006 May 01; 9(3):207-9. PubMed ID: 16721678 [Abstract] [Full Text] [Related]
17. Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: anterior vs. abdominoperineal resection. Wibe A, Syse A, Andersen E, Tretli S, Myrvold HE, Søreide O, Norwegian Rectal Cancer Group. Dis Colon Rectum; 2004 Jan 01; 47(1):48-58. PubMed ID: 14719151 [Abstract] [Full Text] [Related]
18. Tumour location and the effects of preoperative radiotherapy in the treatment of rectal cancer. Holm T, Johansson H, Rutqvist LE, Cedermark B. Br J Surg; 2001 Jun 01; 88(6):839-43. PubMed ID: 11412255 [Abstract] [Full Text] [Related]
20. Results after change of treatment policy for rectal cancer--report from a single hospital in China. Wu AW, Gu J, Wang J, Ye SW, An Q, Yao YF, Zhan TC. Eur J Surg Oncol; 2007 Aug 01; 33(6):718-23. PubMed ID: 17240113 [Abstract] [Full Text] [Related] Page: [Next] [New Search]